Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
every month of non capacity revenue is output that can NOT be caught up, because you can't go beyond capacity. So it's a month's revenue that can not be recovered during the financial year.
we are 3 weeks into april tomorrow, ODX state 2M delivered per week in April, that 6M delivered, or in this case 6M not delivered.
That's anywhere between £10M and £30M revenue lost (some have said each test is £5), compared to £1.5M revenue projected from covid activities for the entire year to 31st march. I'm surprised some of the so called long term investors here are not livid at a lost of revenue exceeding x10 the entire revenue for year ending Mar 2020.
TWatcher, what month is where you live? last time I checked on planet earth we are still in April.
if u not happy why don't u sell you 1 share and move off this bb please.
some investors seem to be unaware that ODX made a firm unambiguous guarantee to deliver 2M LFTs per week in April, I'm surprised at that, but have included the reference to ensure they are fully advised of the quote.
Others don't seem to care that it isn't going to happen (which I flagged for a long time). Maybe its a result of drinking at home since lock down and overdoing it combined with some dubious swiping the wrong way on dating apps, dunno but they should be keeping their eye on the ball.
Just filter. I did ages ago. Sorted!
pubs aren't open you can't even get that fact right, or are you making a wild assumption that I live in the same part of the world as you ?...quite insular if so, are you American ?
Delivering 6M already this month is quite an achievement given TT for mologic not finished, they dont know what antigen test uk gov wants, vistitect tri-antibody test has been available for 6 months without a single order announcement, and abingdon, the lead partner in the RTC antibody consortium have not announced any orders for that lft.
Oh and odx hasn't announced ANY orders or ANY manufacturing output by RNS
Quite the achievement, in fact miraculous if true.
I expect a "taking a little longer" any time now.
https://twitter.com/omegadiagnostic/status/1362040022015348738?s=21
Deliver 2M per week in April
"Omega has CE-marked the product and is now in the process of completing marketing launch for commercial roll-out which is expected to start in April."
Unfortunately looks to be very much in the same mould as ...
'Omega will commercialise the test as a VISITECT® branded product and expects to announce the product's full marketing launch later this month'
One statement form the Antigen RNS, One from the Antibody RNS
There is clearly an issue with Tech Transfer, it has never been expected to take this long, and never before have they separated the news of a tests CE mark with the completion of its tech transfer.
Only 8 working days before we must surely hear some news.
Capacity to produce by the end of April, doesnt mean they will be ?
Twatch, it's always been targeted as the end of april
https://twitter.com/OmegaDiagnostic/status/1359761193620103168
"the technology transfer will conclude in due course"
due course = 20 weeks and counting.
April 2/3rds over. ODX is keeping terribly quiet about these 6M lft tests that they promised to have delivered by now.
TWatcher, thanks for letting me know what you think I need to do. If the device has been CE marked, Omega can produce it. TT describes the process up to and including commercialisation, so, you're right, they haven't launched it yet and they haven't confirmed what numbers that they can produce it in yet, and most importantly they haven't announced any orders yet.
"So, and I think I've mentioned this before, TT happened when CE mark was RNS'd"
You need to phone up and tell the CEO that he's wrong, because in a tweet on the 26/03 he said
"The techonology Transfer process will conclude in due course,but the key milestone has been passed, hence the CE marking"
Clearly thinks the TT did was not concluded when the CE marking was granted, let him know he's wrong.
It looks like from this link that the CC registration is pretty much a administrative step - signing off to say that the product you are manufacturing, which would have been tested is within all EU relevant directives etc. CE marking is your sole and ultimate responsibility as a manufacturer.
" Step 5: Prepare “EC Declaration of Conformity”. You must draw up and sign a written declaration that your product complies with the requirements of all relevant EU legislation which prescribes CE marking (the precise content of such declaration varies depending on the underlying EU legislation). This declaration must be kept together with the technical documentation referred to in Step 3 above, and be made available to the appropriate authorities upon request.
NP. I topped up again today and thought I'd done great at 77p! Well tomorrow is another day!
ATB
Red
Hi Benny,
I don't actually know him but I follow ODX on Twitter and at about 1750 he posted his e mail question and Paul's (Walbrook) response and virtually identical to mine that I received about 1800. I'm sorry I cannot reproduce here but similar to what I posted earlier on LSE. I haven't noticed Neil posting on Twitter before and dont think he is a regular but might be wrong. I replied to him that I had received similar reply from Paul.
ATB
Red
So, and I think I've mentioned this before, TT happened when CE mark was RNS'd and if the statement "...we will be producing 2m tests per week in April.." was correct we could have several million Antigen and Antibody tests produced and waiting to be rolled out. Makes more sense that 140 staff have been doing this than that they've been doing whatever else staff would be doing while there was nothing to be getting on with whilst keeping deathly silent about everything, no? GLA
Good Evening,
On Wednesday I asked the following question of Walbrook....
Question: "I am becoming a little concerned at the constant drop in SP (along with some large sells at end today). Could you just confirm that all is on track for completion of the TT and commercial launch of the VISITECT LFT in April for sale to professional users? "
I received a response this evening which seems consistent to one posted on Twitter this evening by Neil Henshaw
Answer: "In terms of Tech Transfer Omega announced in March that the Company has received CE marking for the test - this means that the process of technology transfer has reached the stage that the Company is satisfied that they are able to reproduce the test to scale to the specifications laid out in the technical files submitted for CE marking, which is positive news. The process is ongoing but the next key milestone is when the product is launched by Omega for sale under their own brand (which surpasses completion of the tech transfer in terms of meaningful news). Nothing has changed in their expectations regarding when this will happen. As you know they have not given a specific date for when the launch will happen so all I can say is that an announcement will be made in due course."
Please note the delay in response from Walbrook is my fault as Paul was not available and I didn't copy in the PR address.
ATB
Red